Literature DB >> 26725159

Nasal exhalation of inhaled beclomethasone hydrofluoroalkane-134a to treat chronic rhinosinusitis.

Satoshi Hamada1, Hisako Matsumoto2, Yoshiki Kobayashi3, Mikiya Asako3, Hirotaka Yasuba4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26725159     DOI： 10.1016/j.jaip.2015.11.018

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  1 in total

1.  HFA-BDP Metered-Dose Inhaler Exhaled Through the Nose Improves Eosinophilic Chronic Rhinosinusitis With Bronchial Asthma: A Blinded, Placebo-Controlled Study.

Authors:  Yoshiki Kobayashi; Hirotaka Yasuba; Mikiya Asako; Takahisa Yamamoto; Hiroshi Takano; Koichi Tomoda; Akira Kanda; Hiroshi Iwai
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.